Clinical trial
Trial Testing Ftorafur (UFT) Associated With Neoadjuvant Radiotherapy Versus…
NCT00207831 · Institut Cancerologie de l'Ouest, Other · Terminated
Key facts
| NCT number | NCT00207831 |
|---|---|
| Title | Trial Testing Ftorafur (UFT) Associated With Neoadjuvant Radiotherapy Versus Radiotherapy Alone in Rectal Adenocarcinoma |
| Official title | Trial UFT/RT Randomized Multicenter Phase III Randomized Trial Testing Ftorafur (UFT) Associated With Neoadjuvant Radiotherapy Versus Radiotherapy Alone in Rectal Adenocarcinoma |
| Acronym | UFT RT Phase 3 |
| Lead sponsor | Institut Cancerologie de l'Ouest, Other |
| Collaborators | Merck Sharp & Dohme LLC Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Rectal Cancer, Stage II/III, T3 or T4 (Only Anal Extension) Rectal Cancer, N0-2, M0 |
| Intervention type | Drug |
| Interventions | Tegafur and Uracil |
| Enrollment | 219 |
| Start date | Jul 1, 2004 |
| Primary completion | Jun 1, 2007 |
| Completion | Feb 1, 2008 |
| First posted | Sep 21, 2005 |
| Last update posted | Mar 25, 2020 |
| Countries | France |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: